Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Antibiotic resistance: A fragile defence

Last defence dam in antimicrobial resistance

Around 25,000 people die in the European Union each year from infections resistant to antibiotics. Third-generation cephalosporins are often useless against common bacteria like Escherichia coli, and fluoroquinolones are no longer the treatment of choice for gonorrhoea because resistance has become widespread. Here, you can find news stories and articles about the issue.

world health organization logo geneva ss 17

Urgent need for new antibiotics to tackle antimicrobial resistance, says WHO

The number of new antibiotics in development is insufficient to mitigate the growing threat of antimicrobial resistance (AMR), according to a report launched by the World Health Organization (WHO).

EMA building

European Medicines Agency to host AMR summit

The European Medicines Agency (EMA) is to host a summit meeting with doctors’ and patients’ organisations, academics, EU member states and the World Health Organization (WHO) to discuss how collaboration can help tackle antimicrobial resistance (AMR).

Antimicrobial susceptibility testing in petri dish

RPS launches major new campaign on antimicrobial stewardship Subscription

By

The Royal Pharmaceutical Society (RPS) has launched a major new campaign calling on all pharmacists to play a greater role in safeguarding antibiotics and minimising the spread of antimicrobial resistance.

New Quick Reference Guide to antimicrobial stewardship Subscription

The Royal Pharmaceutical Society (RPS) has published a new quick reference guide (QRG) to antimicrobial stewardship.

More on antimicrobial resistance

Scanning electron micrograph (SEM) of tuberculosis (TB) bacteria infecting macrophages

Fluoroquinolones for treating tuberculosisSubscription

By , ,

Tuberculosis (TB) remains a significant global health and socioeconomic challenge. The duration of current anti-TB therapies, the adverse effects of certain anti-TB drugs and the growing problem of drug-resistant TB on an international scale mean that it is imperative for new, effective and safe treatment regimens to be developed. Fluoroquinolones are a class of drugs that have been used in the treatment of TB for several decades. This article provides an overview of the current treatment ...

Micrograph of Clostridium difficile bacteria

Clostridium difficile: diagnosis and treatment update

By , , ,

There are around 12,000 cases of Clostridium difficile infection (CDI) each year in the UK and during 1999 to 2007, deaths from CDI peaked at around 4,000 per year. This article summarises diagnosis and management, as well as the current therapeutic options for CDI, including faecal microbiota transplant.

More on antimicrobial resistance

Man on chair measures tangled mess

Science reproducibility crisis: better measurement is required to tackle global health challengesSubscription

Measurement underpins UK trade and regulation, and helps us support innovation and government policy.

Scanning electron micrograph of methicillin-resistant Staphylococcus aureus (MRSA) bacteria

Antimicrobial therapies for Gram-positive infectionsSubscription

By , , ,

Gram-positive bacteria are among the most common human pathogens associated with clinical infections, which range from mild skin infections to sepsis. In an era defined by antimicrobial resistance (AMR) and an increasing drive toward delivering patient care via ambulatory pathways, the paradigm for the management of infections is changing. Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), the best known cases of ...

Impact of non-medical prescribers on AMS and AMR should not be overlookedSubscription

By Negin Sardashti

We read with interest the article ’Pharmacist independent prescribers can make a significant contribution to antimicrobial stewardship’ by Hodson, Deslandes and Courtenay M (The Pharmaceutical Journal 2017;298:313).

gerard water lily 1

Gonorrhoea and antibiotics — past, present and futureSubscription

By John Betts

The problem of dwindling treatment options for gonorrhoea is complicated because there are very few new antibiotics in development. Stewardship of our remaining antibiotic resources is now more urgent than ever.

More on antimicrobial resistance

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Pharmaceutical Journal Jobs

More jobs